adstiladrin.com

.com crawl

First seen 2026-04-28 · Last seen 2026-05-18 · ok HTTP/1.1 200 6779 ms crawled 2026-05-05

US · 3.173.161.82 · AS16509 Amazon.com, Inc.

Reputation 95/100 weak security headers

Classifying

HTML metadata

Title
ADSTILADRIN® (nadofaragene firadenovec-vncg) | NMIBC Treatment
Description
ADSTILADRIN is the first and only FDA-approved gene therapy for treating adult patients with high-risk BCG-unresponsive NMIBC. See Important Safety Info.
Language
en-US
Canonical
https://www.adstiladrin.com/

Open Graph

url
https://www.adstiladrin.com/
title
ADSTILADRIN® (nadofaragene firadenovec-vncg) | NMIBC Treatment
locale
en_US
site name
ADSTILADRIN® (nadofaragene firadenovec-vncg)
description
ADSTILADRIN® is the first and only FDA-approved gene therapy for treating adult patients with high-risk BCG-unresponsive NMIBC. See Important Safety Info.

Technology

CDN
Amazon CloudFront
Server
Apache
CMS
WordPress
Analytics
  • Google Tag Manager
Fonts
  • Google Fonts

Third-party hosts loaded (6)

  • code.jquery.com×2
  • fonts.googleapis.com×2
  • maxcdn.bootstrapcdn.com×2
  • fonts.gstatic.com×1
  • static.ostroapi.com×1
  • www.googletagmanager.com×1

Contact

Phone

Registration

Registrar
Nom-iq Ltd. dba COM LAUDE
Created
2018-05-01
Expires
2027-05-01 346 days left
Updated
2026-04-01
Name servers
  • nsgbr.comlaude.co.uk
  • nssui.comlaude.ch
  • nsusa.comlaude.net

DNS records live

NS
  • nsgbr.comlaude.co.uk
  • nssui.comlaude.ch
  • nsusa.comlaude.net
TXT
  • 46o0un8lkncaptcusvsci10pue
  • google-site-verification=Bjjp1acUQPuhc6QjHuLPaWcN5T3KUNSwXWNHgiV3cTQ

Certificate (current)

Amazon RSA 2048 M01
from 2026-04-10 to 2026-10-25
Expires in 158 days

HTTP security headers

Header hygiene 30/100 Checked live page: https://www.adstiladrin.com/

findings
  • missing HSTS
  • missing Content Security Policy
  • missing frame protection
  • missing content type protection
  • missing Referrer Policy
  • missing Permissions Policy

Links to (5)

Linked from (1)